Literature DB >> 19808243

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

Henriette A C Kyrieleis1, Marije M Löwik, Ilse Pronk, Hans R M Cruysberg, Jan A M Kremer, Wim J G Oyen, Bert L P van den Heuvel, Jack F M Wetzels, Elena N Levtchenko.   

Abstract

BACKGROUND AND OBJECTIVES: Frequently relapsing and steroid-dependent minimal-change nephrotic syndrome (MCNS) that originates in childhood can persist after puberty in >20% of patients. These patients require immunosuppressive treatment during several decades of their life. We examined long-term adverse effects of persistent nephrotic syndrome and immunosuppressive medications, focusing on renal function, growth, obesity, osteoporosis, hypertension, ocular complications, and fertility in adult patients with biopsy-proven childhood-onset MCNS. Molecular analysis was performed to evaluate a possible association of a complicated course of MCNS with podocyte gene mutations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a prospective clinical examination of 15 adult patients that included serum and urine analysis; dual-energy x-ray absorptiometry; ophthalmologic examination; semen examination; and molecular analysis of NPHS1, NPHS2, CD2AP, and ACTN4 genes.
RESULTS: All patients had normal GFR. Most frequent long-term complications were hypertension (in seven of 15 patients) and osteoporosis in one third of patients. Oligozoospermia was found in one patient, reduced sperm motility in four of eight patients, and teratozoospermia in six of eight patients. Ophthalmologic examination revealed myopia in 10 of 15 patients and cataract in three of 15 patients.
CONCLUSIONS: Children with MCNS that persists after puberty are at risk for complications such as osteoporosis, hypertension, cataract, and sperm abnormalities. Our study underscores a need for more effective and less toxic therapies for relapsing MCNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808243      PMCID: PMC2758253          DOI: 10.2215/CJN.05691108

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  40 in total

1.  NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele.

Authors:  Hiroyasu Tsukaguchi; Akulapalli Sudhakar; Tu Cam Le; Trang Nguyen; Jun Yao; Joshua A Schwimmer; Asher D Schachter; Esteban Poch; Patricia F Abreu; Gerald B Appel; Aparecido B Pereira; Raghu Kalluri; Martin R Pollak
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

3.  Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.

Authors:  Nike M M L Stikkelbroeck; Wim J G Oyen; Gert-Jan van der Wilt; Ad R M M Hermus; Barto J Otten
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome.

Authors:  O Beltcheva; P Martin; U Lenkkeri; K Tryggvason
Journal:  Hum Mutat       Date:  2001-05       Impact factor: 4.878

5.  Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.

Authors:  R Bogdanović; M Banićević; A Cvorić
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

6.  Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy.

Authors:  Yoriko Hayasaka; Seiji Hayasaka; Hiroyoshi Matsukura
Journal:  Ophthalmologica       Date:  2006       Impact factor: 3.250

7.  Steroid-sensitive nephrotic syndrome: from childhood to adulthood.

Authors:  Fadi Fakhouri; Nathalie Bocquet; Pierre Taupin; Claire Presne; Marie-France Gagnadoux; Paul Landais; Philippe Lesavre; Dominique Chauveau; Bertrand Knebelmann; Michel Broyer; Jean-Pierre Grünfeld; Patrick Niaudet
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

8.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

9.  Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.

Authors:  Marije Löwik; Elena Levtchenko; Dineke Westra; Patricia Groenen; Eric Steenbergen; Jan Weening; Marc Lilien; Leo Monnens; Lambert van den Heuvel
Journal:  Nephrol Dial Transplant       Date:  2008-04-28       Impact factor: 5.992

10.  Long-term linear growth of children with severe steroid-responsive nephrotic syndrome.

Authors:  Francesco Emma; Antonella Sesto; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-06-13       Impact factor: 3.714

View more
  54 in total

1.  Pediatrics: how 'minimal' are the adult consequences of childhood MCNS?

Authors:  Kevin V Lemley
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

2.  Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.

Authors:  Vaishnavi Raman; Sriram Krishnamurthy; K T Harichandrakumar
Journal:  Pediatr Nephrol       Date:  2016-01-12       Impact factor: 3.714

Review 3.  New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Authors:  Michael van Husen; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-01-13       Impact factor: 3.714

4.  Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.

Authors:  Menka Yadav; Aditi Sinha; Priyanka Khandelwal; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2018-09-07       Impact factor: 3.714

5.  American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.

Authors:  Fernando C Fervenza; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 6.  Regulatory T cells and minimal change nephropathy: in the midst of a complex network.

Authors:  R Bertelli; A Bonanni; A Di Donato; M Cioni; P Ravani; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2015-10-12       Impact factor: 4.330

Review 7.  The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.

Authors:  Sebastian Kummer; Gero von Gersdorff; Markus J Kemper; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

8.  Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Naoto Nishizaki; Tomonosuke Someya; Yoshiyuki Ohtomo; Yoshikazu Ohtsuka; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2010-12-21       Impact factor: 3.714

9.  Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome.

Authors:  Vijay Agrawal; Kusum Devpura; Laxmikant Mishra; Sajan Agarwal
Journal:  J Clin Diagn Res       Date:  2017-03-01

10.  Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.

Authors:  Xiao-Ling Niu; Sheng Hao; Ping Wang; Wei Zhang; Gui-Mei Guo; Ying Wu; Xin-Yu Kuang; Guang-Hua Zhu; Wen-Yan Huang
Journal:  Biomed Rep       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.